US Stock MarketDetailed Quotes
HUMA Humacyte
- 6.010
- -0.640-9.62%
Close Aug 14 16:00 ET
- 6.050
- +0.040+0.67%
Post 19:17 ET
717.30MMarket Cap-4732P/E (TTM)
6.660High6.010Low3.99MVolume6.650Open6.650Pre Close24.71MTurnover4.79%Turnover RatioLossP/E (Static)119.35MShares9.97052wk High-25.36P/B500.00MFloat Cap1.96052wk Low--Dividend TTM83.19MShs Float17.450Historical High--Div YieldTTM9.77%Amplitude1.960Historical Low6.199Avg Price1Lot Size
Humacyte Stock Forum
Sign in to post a comment
$Humacyte (HUMA.US)$ looks like government insiders wanted one more chance to get in first. someone bought that dip hard
1
Nasty drop AH. Here are the levels to watch when the dust settles.
Larger Image: tradingview.com...
$Humacyte (HUMA.US)$
Larger Image: tradingview.com...
$Humacyte (HUMA.US)$
1
$Humacyte (HUMA.US)$ should have sold when 50% profit now sold around breakeven wasted 23 days hard lesson , never overstaying again in anything 👍all holders
loading...
3
1
$Humacyte (HUMA.US)$
Humacyte Announces FDA Communication of Additional Time Required to Complete Review of acellular tissue engineered vessel (ATEV™) BLA for the Treatment of Vascular Trauma
Humacyte (Nasdaq: HUMA) announced that the FDA requires additional time to review its Biologic License Application (BLA) for the acellular tissue engineered vessel (ATEV) in vascular trauma treatment. The FDA granted Priority Review in February 2024 with a PDUFA date of August 10, 2024. Despite active en...
Humacyte Announces FDA Communication of Additional Time Required to Complete Review of acellular tissue engineered vessel (ATEV™) BLA for the Treatment of Vascular Trauma
Humacyte (Nasdaq: HUMA) announced that the FDA requires additional time to review its Biologic License Application (BLA) for the acellular tissue engineered vessel (ATEV) in vascular trauma treatment. The FDA granted Priority Review in February 2024 with a PDUFA date of August 10, 2024. Despite active en...
5
$Humacyte (HUMA.US)$ fda news today....... maybe
4
$Humacyte (HUMA.US)$ keeping my position. you got government in this and a big catalyst on Saturday. if all goes well we have a possible big upside tomorrow or Monday. feels like a safe play with minimal loss vs huge upside
$Humacyte (HUMA.US)$
Support and Resistance Levels
Support Level: $8.995-identified key support level
Clear Support Level: $9.75-identified through price consolidation
Resistance Level: $8.789-recent high 📈
These levels are crucial as they indicate potential price floors and ceilings, guiding entry and exit points.
Support and Resistance Levels
Support Level: $8.995-identified key support level
Clear Support Level: $9.75-identified through price consolidation
Resistance Level: $8.789-recent high 📈
These levels are crucial as they indicate potential price floors and ceilings, guiding entry and exit points.
1
4
so I am still holding this slow killer thing$Humacyte (HUMA.US)$ same price action different recent weeks , if goes up $1 comes down $1.5 , going to take profit i am almost done if unable to test $10 within 3 days i am out….
3
10
🚨 This Week’s PDUFA:
$Humacyte (HUMA.US)$ : 🤔
⇨ Human Acellular Vessel (HAV)™
‣ Vascular Trauma
‣ PDUFA: 8/10/24 (BLA)
🗓️ Last Week’s AdCom & PDUFAs:
$Zevra Therapeutics (ZVRA.US)$ : Favorable AdCom 👍
🗳️ 11-5 votes in favor
⇨ Arimoclomol
‣ Niemann-Pick disease type C
‣ AdCom: 8/2/24 (NDA)
$Adaptimmune Therapeutics (ADAP.US)$ : Approved 🎉
⇨ TECELRA (afamitresgene autoleucel)
‣ Synovial sarcoma
‣ PDUFA: 8/4/24 (BLA)
$GlaxoSmithKline (GSK.US)$ : Approved 🎉
⇨ Jemperli
‣ Endometria...
$Humacyte (HUMA.US)$ : 🤔
⇨ Human Acellular Vessel (HAV)™
‣ Vascular Trauma
‣ PDUFA: 8/10/24 (BLA)
🗓️ Last Week’s AdCom & PDUFAs:
$Zevra Therapeutics (ZVRA.US)$ : Favorable AdCom 👍
🗳️ 11-5 votes in favor
⇨ Arimoclomol
‣ Niemann-Pick disease type C
‣ AdCom: 8/2/24 (NDA)
$Adaptimmune Therapeutics (ADAP.US)$ : Approved 🎉
⇨ TECELRA (afamitresgene autoleucel)
‣ Synovial sarcoma
‣ PDUFA: 8/4/24 (BLA)
$GlaxoSmithKline (GSK.US)$ : Approved 🎉
⇨ Jemperli
‣ Endometria...
5
$Humacyte (HUMA.US)$
you mean it's about to go 99% don't tell nobody
you mean it's about to go 99% don't tell nobody
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
72839823 : Nancy Pelosi